Skip to main content

UTHSC professor's startup receives federal grants, LaunchTN funds for leukemia therapy

Wei Li is the founder of SEAK Therapeutics, a UTHSC-connected startup that’s in the early stages of developing a compound called SEAK-114, which is expected to act as a targeted leukemia therapy.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.